Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Aug-10 5:18 PM View:  | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 2,789 | $14.00 | $39,042.20 | (1%) 272.44K to 269.65K | 2% |
| 11-Aug-10 5:31 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 2,812 | $14.00 | $39,364.20 | (< 1%) 1.1M to 1.1M | 2% |
| 11-Aug-10 5:22 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 34,462 | $14.00 | $482,421.00 | (1%) 3.36M to 3.33M | 2% |
| 11-Aug-10 5:24 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 1,877 | $14.00 | $26,275.50 | (1%) 183.24K to 181.36K | 2% |
| 11-Aug-10 5:21 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 88,250 | $14.00 | $1,235,380.00 | (1%) 8.62M to 8.53M | 2% |
| 11-Aug-10 5:31 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 9,991 | $14.08 | $140,710.00 | (< 1%) 1.11M to 1.1M | 3% |
| 11-Aug-10 5:22 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 122,467 | $14.08 | $1,724,780.00 | (4%) 3.49M to 3.36M | 3% |
| 10-Aug-10 4:08 PM View: | Chardonnet Laurent | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 15,618 | $14.06 | $219,535.00 | (75%) 20.96K to 5.34K | (< 1%) |
| 11-Aug-10 5:24 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 6,670 | $14.08 | $93,938.00 | (4%) 189.91K to 183.24K | 3% |
| 11-Aug-10 5:21 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 313,622 | $14.08 | $4,416,950.00 | (4%) 8.93M to 8.62M | 3% |
| 11-Aug-10 5:18 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 9,916 | $14.08 | $139,654.00 | (4%) 282.35K to 272.44K | 3% |
| 10-Aug-10 4:09 PM View: | Schreck Patricia A EVP, General Counsel | Incyte Corp (INCY) | 06-Aug-10 | Option Exercise | 94,960 | $6.15 | $584,004.00 | 2110% 4.5K to 99.46K | |
| 10-Aug-10 4:09 PM View: | Schreck Patricia A EVP, General Counsel | Incyte Corp (INCY) | 06-Aug-10 | Market Option Sale | 94,960 | $13.88 | $1,318,250.00 | (95%) 99.46K to 4.5K | (2%) |
| 08-Jul-10 4:08 PM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 07-Jul-10 | Option Exercise | 25,142 | $6.17 | $155,034.00 | 10% 264.56K to 289.71K | |
| 06-Jul-10 7:51 AM View: | Hastings David C Chief Financial Officer | Incyte Corp (INCY) | 01-Jul-10 | Market Purchase | 2,000 | $10.24 | $20,480.00 | 31% 6.5K to 8.5K | 5% |
| 06-Jul-10 7:50 AM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 01-Jul-10 | Market Purchase | 10,000 | $10.43 | $104,257.00 | 4% 254.56K to 264.56K | 3% |
| 21-Jun-10 4:10 PM View: | Swain Paula J EVP, Human Resources | Incyte Corp (INCY) | 17-Jun-10 | Market Option Sale | 97,917 | $13.15 | $1,287,610.00 | (100%) 97.92K to 0 | (< 1%) |
| 21-Jun-10 4:10 PM View: | Swain Paula J EVP, Human Resources | Incyte Corp (INCY) | 17-Jun-10 | Option Exercise | 97,917 | $6.05 | $592,064.00 | 100% 0 to 97.92K | |
| 17-Mar-10 4:41 PM View: | Levy Richard S EVP, Chief Drug Dev&Medical Of | Incyte Corp (INCY) | 15-Mar-10 | Option Exercise | 20,000 | $4.19 | $83,800.00 | 100% 0 to 20.0K | |
| 17-Mar-10 4:41 PM View: | Levy Richard S EVP, Chief Drug Dev&Medical Of | Incyte Corp (INCY) | 15-Mar-10 | Market Option Sale | 20,000 | $12.94 | $258,800.00 | (100%) 20.0K to 0 | (< 1%) |
| 08-Jan-10 4:29 PM View: | Friedman Steven M. EVP, Biology & Preclinical Dev | Incyte Corp (INCY) | 08-Jan-10 | Market Sale | 22,000 | $10.90 | $239,800.00 | (37%) 60.14K to 38.14K | < 1% |
| 25-Jan-10 4:58 PM View: | Whitfield Roy A Director | Incyte Corp (INCY) | 22-Dec-09 | Gift | 10,000 | -- | -- | (1%) 971.34K to 961.34K | |
| 28-Sep-09 9:14 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 24-Sep-09 | Grant | 1,848,200 | $6.75 | $12,475,400.00 | 26% 7.08M to 8.93M | (2%) |
| 28-Sep-09 8:48 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 24-Sep-09 | Grant | 101,506 | $6.75 | $685,166.00 | 56% 180.85K to 282.35K | (2%) |
| 28-Sep-09 8:45 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 24-Sep-09 | Grant | 50,294 | $6.75 | $339,484.00 | 36% 139.62K to 189.91K | (2%) |
| 10-Mar-09 4:33 PM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 09-Mar-09 | Market Purchase | 9,400 | $2.10 | $19,740.00 | 4% 245.16K to 254.56K | 7% |
| 10-Mar-09 4:33 PM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 06-Mar-09 | Market Purchase | 10,600 | $2.10 | $22,260.00 | 5% 234.56K to 245.16K | 7% |
| 05-Mar-09 5:19 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 312 | $2.16 | $673.14 | < 1% 180.54K to 180.85K | 4% |
| 05-Mar-09 4:41 PM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 8,840 | $2.20 | $19,448.00 | 4% 225.72K to 234.56K | 2% |
| 05-Mar-09 6:16 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 64 | $2.16 | $138.08 | < 1% 139.55K to 139.62K | 4% |
| 05-Mar-09 5:51 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 5 | $2.16 | $10.79 | < 1% 568.89K to 568.89K | 4% |
| 05-Mar-09 6:03 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 1,248 | $2.16 | $2,692.56 | < 1% 3.49M to 3.49M | 4% |
| 05-Mar-09 5:31 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 11,232 | $2.16 | $24,233.00 | < 1% 7.07M to 7.08M | 4% |
| 05-Mar-09 6:16 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 98 | $2.14 | $209.88 | < 1% 139.45K to 139.55K | 5% |
| 05-Mar-09 5:51 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 5 | $2.14 | $10.71 | < 1% 568.88K to 568.89K | 5% |
| 05-Mar-09 6:03 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 2,199 | $2.14 | $4,709.38 | < 1% 3.48M to 3.49M | 5% |
| 05-Mar-09 5:31 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 9,524 | $2.14 | $20,396.60 | < 1% 7.06M to 7.07M | 5% |
| 05-Mar-09 5:19 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 264 | $2.14 | $565.38 | < 1% 180.27K to 180.54K | 5% |
| 05-Mar-09 4:41 PM View: | Friedman Paul A Chief Executive Officer Director | Incyte Corp (INCY) | 03-Mar-09 | Market Purchase | 11,160 | $2.20 | $24,552.00 | 5% 214.56K to 225.72K | 2% |
| 02-Mar-09 8:05 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 17 | $2.15 | $36.60 | < 1% 568.85K to 568.87K | 4% |
| 02-Mar-09 6:40 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 7,701 | $2.15 | $16,579.80 | < 1% 3.48M to 3.48M | 4% |
| 02-Mar-09 4:40 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 33,364 | $2.15 | $71,830.90 | < 1% 7.03M to 7.06M | 4% |
| 02-Mar-09 4:49 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 927 | $2.15 | $1,995.77 | < 1% 179.34K to 180.27K | 4% |
| 02-Mar-09 7:34 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 02-Mar-09 | Market Purchase | 343 | $2.15 | $738.46 | < 1% 139.11K to 139.45K | 4% |
| 19-Dec-08 6:08 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 7,772 | $3.60 | $27,969.30 | 2% 336.89K to 344.66K | (38%) |
| 19-Dec-08 6:52 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 1,927 | $3.60 | $6,934.75 | 1% 137.18K to 139.11K | (38%) |
| 19-Dec-08 7:12 PM View: | Baker Bros Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 1,454 | $3.60 | $5,232.55 | < 1% 1.99M to 1.99M | (38%) |
| 19-Dec-08 7:24 PM View: | Baker Biotech Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 89,241 | $3.60 | $321,154.00 | 3% 3.39M to 3.48M | (38%) |
| 19-Dec-08 6:38 PM View: | Baker Biotech Capital III (... Director 10% Owner | Incyte Corp (INCY) | 19-Dec-08 | Market Purchase | 284,546 | $3.60 | $1,024,000.00 | 4% 6.74M to 7.03M | (38%) |
| 19-Dec-08 6:52 PM View: | Baker Tisch Capital Gp LLC Director 10% Owner | Incyte Corp (INCY) | 18-Dec-08 | Market Purchase | 1,628 | $3.57 | $5,804.15 | 1% 135.56K to 137.18K | (37%) |
